Cargando…

The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome

Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are diseases caused by the interaction of genetic and non-genetic factors. Therefore, the aim of our study was to investigate the association between six common genetic polymorphisms and T2DM and MetS in males. A total of 120 T2DM, 75 Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Zenoaga-Barbăroșie, C, Berca, L, Vassu-Dimov, T, Toma, M, Nica, MI, Alexiu-Toma, OA, Ciornei, C, Albu, A, Nica, S, Nistor, C, Nica, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413885/
https://www.ncbi.nlm.nih.gov/pubmed/37576792
http://dx.doi.org/10.2478/bjmg-2023-0003
_version_ 1785087227303297024
author Zenoaga-Barbăroșie, C
Berca, L
Vassu-Dimov, T
Toma, M
Nica, MI
Alexiu-Toma, OA
Ciornei, C
Albu, A
Nica, S
Nistor, C
Nica, R
author_facet Zenoaga-Barbăroșie, C
Berca, L
Vassu-Dimov, T
Toma, M
Nica, MI
Alexiu-Toma, OA
Ciornei, C
Albu, A
Nica, S
Nistor, C
Nica, R
author_sort Zenoaga-Barbăroșie, C
collection PubMed
description Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are diseases caused by the interaction of genetic and non-genetic factors. Therefore, the aim of our study was to investigate the association between six common genetic polymorphisms and T2DM and MetS in males. A total of 120 T2DM, 75 MetS, and 120 healthy controls (HC) were included in the study. ACE ID, eNOS 4a/b, ATR1 A1166C, OXTR (A>G), SOD1 +35A/C, CAT-21A/T gene polymorphisms were genotyped by PCR or PCR-RFLP techniques. T2DM was diagnosed at an earlier age compared to MetS (54 vs 55 years old, p=0.0003) and the difference was greater in carriers of the OXTR G allele (54 vs 56 years old, p=0.0002) or both OXTR G and eNOS b alleles (54 vs 56, p=0.00016). The SOD1 AA genotype (O.R.=0.11, p=0.0006) and the presence of both ACE I and OXTR1 A (O.R.=0.39, p=0.0005) alleles revealed to be protective for T2DM. SOD1 AA and AC genotypes were protective factors for triglyceride (p=0.0002 and p=0.0005, respectively) and HDL cholesterol (p=0.0002 and p=0.0004, respectively) levels in T2DM patients. ACE DD was identified more frequently in hypertensive T2DM patients (O.R.=3.77, p=0.0005) and in those who reported drinking alcohol (p=0.0001) comparing to HC and T2DM patients who did not drink alcohol, respectively. We observed that T2DM patients who reported drinking alcohol had an increased frequency of ACE DD and eNOS bb (p<0.0001), or ACE DD and OXTR G (p<0.0001) compared to non-drinkers. No gene polymorphisms were associated with MetS.
format Online
Article
Text
id pubmed-10413885
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-104138852023-08-11 The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome Zenoaga-Barbăroșie, C Berca, L Vassu-Dimov, T Toma, M Nica, MI Alexiu-Toma, OA Ciornei, C Albu, A Nica, S Nistor, C Nica, R Balkan J Med Genet Original Article Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are diseases caused by the interaction of genetic and non-genetic factors. Therefore, the aim of our study was to investigate the association between six common genetic polymorphisms and T2DM and MetS in males. A total of 120 T2DM, 75 MetS, and 120 healthy controls (HC) were included in the study. ACE ID, eNOS 4a/b, ATR1 A1166C, OXTR (A>G), SOD1 +35A/C, CAT-21A/T gene polymorphisms were genotyped by PCR or PCR-RFLP techniques. T2DM was diagnosed at an earlier age compared to MetS (54 vs 55 years old, p=0.0003) and the difference was greater in carriers of the OXTR G allele (54 vs 56 years old, p=0.0002) or both OXTR G and eNOS b alleles (54 vs 56, p=0.00016). The SOD1 AA genotype (O.R.=0.11, p=0.0006) and the presence of both ACE I and OXTR1 A (O.R.=0.39, p=0.0005) alleles revealed to be protective for T2DM. SOD1 AA and AC genotypes were protective factors for triglyceride (p=0.0002 and p=0.0005, respectively) and HDL cholesterol (p=0.0002 and p=0.0004, respectively) levels in T2DM patients. ACE DD was identified more frequently in hypertensive T2DM patients (O.R.=3.77, p=0.0005) and in those who reported drinking alcohol (p=0.0001) comparing to HC and T2DM patients who did not drink alcohol, respectively. We observed that T2DM patients who reported drinking alcohol had an increased frequency of ACE DD and eNOS bb (p<0.0001), or ACE DD and OXTR G (p<0.0001) compared to non-drinkers. No gene polymorphisms were associated with MetS. Sciendo 2023-07-31 /pmc/articles/PMC10413885/ /pubmed/37576792 http://dx.doi.org/10.2478/bjmg-2023-0003 Text en © 2023 C Zenoaga-Barbăroșie et al., published by Sciendo https://creativecommons.org/licenses/by-nc-nd/3.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
spellingShingle Original Article
Zenoaga-Barbăroșie, C
Berca, L
Vassu-Dimov, T
Toma, M
Nica, MI
Alexiu-Toma, OA
Ciornei, C
Albu, A
Nica, S
Nistor, C
Nica, R
The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
title The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
title_full The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
title_fullStr The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
title_full_unstemmed The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
title_short The Predisposition for Type 2 Diabetes Mellitus and Metabolic Syndrome
title_sort predisposition for type 2 diabetes mellitus and metabolic syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413885/
https://www.ncbi.nlm.nih.gov/pubmed/37576792
http://dx.doi.org/10.2478/bjmg-2023-0003
work_keys_str_mv AT zenoagabarbarosiec thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT bercal thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT vassudimovt thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT tomam thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT nicami thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT alexiutomaoa thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT ciorneic thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT albua thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT nicas thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT nistorc thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT nicar thepredispositionfortype2diabetesmellitusandmetabolicsyndrome
AT zenoagabarbarosiec predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT bercal predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT vassudimovt predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT tomam predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT nicami predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT alexiutomaoa predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT ciorneic predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT albua predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT nicas predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT nistorc predispositionfortype2diabetesmellitusandmetabolicsyndrome
AT nicar predispositionfortype2diabetesmellitusandmetabolicsyndrome